Stage 2 prostate adenocarcinoma is localized, with a nearly 100%, five-year relative survival rate. Diagnosis uses the TNM system, PSA levels and Gleason score to determine cancer stage and risk.
Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.